Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no changes to core content, study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page. No visible changes to study content or page behavior.SummaryDifference0.0%

- Check58 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and may not all pertain to the study, adding clarity on content provenance. The revision tag has changed from v3.2.0 to v3.3.1 and the previous wording was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe government funding lapse notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedNo additions or deletions were detected. The study details and related sections appear unchanged.SummaryDifference0.4%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.